Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis

Detalhes bibliográficos
Autor(a) principal: Brazão, SG
Data de Publicação: 2019
Outros Autores: Crespo, J, Carvalho, A
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.4/2230
Resumo: Introduction: Behçet’s disease (BD) is a chronic systemic condition characterized by recurrent oral and genital ulcers, neurological and vascular manifestations, ocular and skin lesions, and a positive pathergy test. Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome is rare and consists of features of BD together with relapsing polychondritis. The treatment of this syndrome is similar that of BD and depends on disease expression and symptoms. Case report: We report the case of a 50-year-old man diagnosed with BD with relapsing polychondritis (MAGIC syndrome) which had evolved over approximately 35 years, with exuberant and frequent oral and genital ulcers. Various treatments were unsuccessful and had adverse effects. Lenalidomide was initiated at a dose of 5 mg per day with remission of oral and genital ulcers and no haematological or adverse effects. Conclusion: BD is a complex disorder with a variety of presentations. Its treatment can be challenging but sometimes off-label drugs, like lenalidomide, can be effective.
id RCAP_8319287d0c9c1207400fdae48cfb292e
oai_identifier_str oai:rihuc.huc.min-saude.pt:10400.4/2230
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing PolychondritisDoença de BehçetLenalidomidaPolicondrite RecidivanteIntroduction: Behçet’s disease (BD) is a chronic systemic condition characterized by recurrent oral and genital ulcers, neurological and vascular manifestations, ocular and skin lesions, and a positive pathergy test. Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome is rare and consists of features of BD together with relapsing polychondritis. The treatment of this syndrome is similar that of BD and depends on disease expression and symptoms. Case report: We report the case of a 50-year-old man diagnosed with BD with relapsing polychondritis (MAGIC syndrome) which had evolved over approximately 35 years, with exuberant and frequent oral and genital ulcers. Various treatments were unsuccessful and had adverse effects. Lenalidomide was initiated at a dose of 5 mg per day with remission of oral and genital ulcers and no haematological or adverse effects. Conclusion: BD is a complex disorder with a variety of presentations. Its treatment can be challenging but sometimes off-label drugs, like lenalidomide, can be effective.RIHUCBrazão, SGCrespo, JCarvalho, A2019-07-02T12:05:20Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.4/2230engEur J Case Rep Intern Med. 2019;6(6)10.12890/2019_001117info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-11T14:23:36Zoai:rihuc.huc.min-saude.pt:10400.4/2230Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:04:41.663309Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
title Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
spellingShingle Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
Brazão, SG
Doença de Behçet
Lenalidomida
Policondrite Recidivante
title_short Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
title_full Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
title_fullStr Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
title_full_unstemmed Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
title_sort Lenalidomide: An Alternative Treatment for Refractory Behçet’s Disease and Relapsing Polychondritis
author Brazão, SG
author_facet Brazão, SG
Crespo, J
Carvalho, A
author_role author
author2 Crespo, J
Carvalho, A
author2_role author
author
dc.contributor.none.fl_str_mv RIHUC
dc.contributor.author.fl_str_mv Brazão, SG
Crespo, J
Carvalho, A
dc.subject.por.fl_str_mv Doença de Behçet
Lenalidomida
Policondrite Recidivante
topic Doença de Behçet
Lenalidomida
Policondrite Recidivante
description Introduction: Behçet’s disease (BD) is a chronic systemic condition characterized by recurrent oral and genital ulcers, neurological and vascular manifestations, ocular and skin lesions, and a positive pathergy test. Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome is rare and consists of features of BD together with relapsing polychondritis. The treatment of this syndrome is similar that of BD and depends on disease expression and symptoms. Case report: We report the case of a 50-year-old man diagnosed with BD with relapsing polychondritis (MAGIC syndrome) which had evolved over approximately 35 years, with exuberant and frequent oral and genital ulcers. Various treatments were unsuccessful and had adverse effects. Lenalidomide was initiated at a dose of 5 mg per day with remission of oral and genital ulcers and no haematological or adverse effects. Conclusion: BD is a complex disorder with a variety of presentations. Its treatment can be challenging but sometimes off-label drugs, like lenalidomide, can be effective.
publishDate 2019
dc.date.none.fl_str_mv 2019-07-02T12:05:20Z
2019
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.4/2230
url http://hdl.handle.net/10400.4/2230
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Eur J Case Rep Intern Med. 2019;6(6)
10.12890/2019_001117
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131709500817408